Elidah

Monroe, United States Founded: 2014 • Age: 12 yrs
Non-invasive wearable devices for pelvic floor muscle strengthening are offered.

About Elidah

Elidah is a Healthcare company based in Monroe (United States) founded in 2014 by Gloria Kolb and Eric Kolb. Non-invasive wearable devices for pelvic floor muscle strengthening are offered. It operates in the Healthcare and Technology sectors. Elidah has raised $2.02 million across 3 funding rounds from investors including America’s Seed Fund and National Science Foundation. Its chief executive, as recorded, is Gloria Kolb. Elidah offers products and services including Elitone and Elitone URGE. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its competitors include Axonics, NeuSpera Medical and Levee Medical; 3 of its 3 listed competitors have raised funding.

Company details

Elidah was founded in 2014 and is based in Monroe, United States. A non-invasive, discreet wearable device is provided for home use to stimulate and strengthen pelvic floor muscles. Urinary incontinence is addressed through this technology, which avoids vaginal insertion. Operations focus on health technology for womens pelvic health, with development led by co-founders Gloria Kolb as CEO and Eric Kolb as CTO.

  • Headquarters Monroe, United States
  • Founders Gloria Kolb, Eric Kolb
  • Sectors
    Healthcare
    Technology
  • Website elidah.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $2.02M (USD)

    in 3 rounds

  • Latest Funding Round
    $2.02M (USD), Seed

    Jun 2023

  • Investors

Products & Services of Elidah

Elidah offers a comprehensive portfolio of products and services, including Elitone and Elitone URGE.

Elitone
Pelvic Floor Therapy

External device for treating stress urinary incontinence effectively.

Elitone URGE
Pelvic Floor Therapy

Device designed for managing urge urinary incontinence daily.

Funding Insights of Elidah

Elidah has successfully raised a total of $2.02M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $2.02 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.02M
  • Total Rounds 3
  • Last Round Seed — $2.02M
  • First Round $179,999

    (Jul 2015)

  • Investors Count 2

All 3 funding rounds of Elidah with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2023$2.02MSeed––
–
Sep 2016$909,999Grant––
Jul 2015$179,999Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in Elidah

Elidah has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund and National Science Foundation.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Venture capital fund backed by the US Government
seedfund.nsf.govAlexandria, United States
A government-backed foundation providing seed-stage investments to support small businesses.
1950nsf.govArlington, United States
Premium access

Investor details for Elidah

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Elidah

5 people are tracked at Elidah (4 in leadership, 1 in team).

NameRoleGroup
Gloria Kolb
Co-Founder & CEOLeadership
Eric Kolb
Co-Founder & CTOLeadership
Gloria K.
CEOLeadership
Ralph Lombardo
Chief Business OfficerLeadership
Farrell Brown
EngineerTeam
Premium access

Complete people profiles for Elidah

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Elidah

3 dated milestones of Elidah across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded Elidah is founded.
  2. Funding First funding round of $180K.
  3. Funding Latest funding round, Seed, of $2.0M.

Competitors of Elidah

Elidah has 3 listed competitors in our database, 3 of them funded. They include Axonics, NeuSpera Medical and Levee Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
axonics.com2013Irvine, United States$143.47M762
Sacral neuromodulation devices are developed for urinary and bowel control.
neuspera.com2014Santa Clara, United States$123.59M
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
leveemedical.com2021Durham, United States$24.15M
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
Premium access

Detailed competitors of Elidah

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Genitourinary Disorders

3 companies that operate in the same segment as Elidah (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
2012Malvern, Pennsylvania, United StatesUSD 104.6 MUSD 80.28 M209
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Elidah

Premium access

Complete news archive for Elidah

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Elidah

Elidah was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Elidah is headquartered in Monroe, United States.

Gloria Kolb is the CEO of Elidah, as recorded in our data. They have also founded this company.

Elidah is a funded company, having raised a total of $2.02M across 3 funding rounds to date. The company's 1st funding round was a Grant of $180K, raised on Jul 2015.

Elidah was founded in 2014 and is based in Monroe, United States. A non-invasive, discreet wearable device is provided for home use to stimulate and strengthen pelvic floor muscles. Urinary incontinence is addressed through this technology, which avoids vaginal insertion. Operations focus on health technology for womens pelvic health, with development led by co-founders Gloria Kolb as CEO and Eric Kolb as CTO.

Elidah's top competitors include Axonics, NeuSpera Medical and Levee Medical.

Elidah offers Elitone and Elitone URGE.

Elidah has 2 investors. Key investors include America’s Seed Fund, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available